MISSIONPHARMA GROUP ApS: Financial statements 2015
CVR: 29782792
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
MISSIONPHARMA GROUP ApS (CVR 29782792) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -99,000 and a net result of DKK 68,442,000 compared with DKK 63,331,000 the year before. Equity in the 2015 report amounted to DKK 289,837,000. The solvency ratio was 99%. The company had 136 employees in the financial year.
- Revenue
- DKK 0
- Gross Profit
- DKK -99,000
- Profit/Loss
- DKK 68,442,000
- Equity
- DKK 289,837,000
- Total Assets
- DKK 292,634,000
- Employees
- 136
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | 0 | -99 t. | 68.4 mio. | 289.8 mio. | 136 |
| 2014 | 0 | -57 t. | 63.3 mio. | 272 mio. | 111 |
| 2013 | 0 | -122 t. | 39.4 mio. | 239.5 mio. | 104 |
Official annual report
How creditworthy is MISSIONPHARMA GROUP ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
MISSIONPHARMA GROUP ApS has published its annual report for 2014. Revenue came to DKK 0, and the net result was DKK 63,331,000.
As of April 20, 2015, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of MISSIONPHARMA GROUP ApS.
As of April 20, 2015, KPMG P/S has stepped down as auditor of MISSIONPHARMA GROUP ApS.
About MISSIONPHARMA GROUP ApS
MISSIONPHARMA GROUP ApS was a Danish company of the type Anpartsselskab based in Lynge, founded in 2006. The company has been dissolved on 15 December 2023. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named MIFAMED HOLDING ApS and MISSIONPHARMA HOLDING ApS. According to the 2023 annual report, the company had an average of 150 employees. In 2023, the company reported a gross profit of DKK -110,000 and a net result of DKK 118,139,000 compared with DKK 52,312,000 the year before. Equity in the 2023 report amounted to DKK 349,722,000.